Supplement's "enhancement" drives recall

Novacare is recalling all lots of a male sexual enhancement supplement distributed before mid-June. The recall follows the FDA's finding that the products--encompassing some 21 imaginatively named brands--"appear to contain sulfoaildenafil," which is undeclared on the labels. Sulfoaildenafil is a cousin to Sildenafil, more commonly known as Viagra. The products were distributed in bottles and blister cards to brick-and-mortar and online retailers. Recall notice 

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.